Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.17%
1,106.36
-1.87
-0.17%
1,108.231,109.651,115.881,105.59
SIXC
Communications
SIXC
Communications
SIXC
+0.77%
610.29
+4.66
+0.77%
605.63605.63611.69602.96
SIXE
Energy
SIXE
Energy
SIXE
+0.10%
1,211.22
+1.27
+0.10%
1,209.951,210.981,212.701,197.20
SIXI
Industrials
SIXI
Industrials
SIXI
-0.43%
1,750.71
-7.52
-0.43%
1,758.231,759.031,760.641,739.69
SIXM
Financials
SIXM
Financials
SIXM
-1.07%
628.17
-6.77
-1.07%
634.94632.49632.49627.63
SIXR
Staples
SIXR
Staples
SIXR
+0.26%
854.57
+2.20
+0.26%
852.37850.81859.97849.13
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.90%
216.87
-1.98
-0.90%
218.85218.85218.85215.61
SIXT
Technology
SIXT
Technology
SIXT
+0.95%
3,561.94
+33.45
+0.95%
3,528.493,565.203,578.773,509.18
SIXU
Utilities
SIXU
Utilities
SIXU
-1.26%
903.31
-11.51
-1.26%
914.82910.36910.36897.78
SIXV
Health care
SIXV
Health care
SIXV
+0.63%
1,481.54
+9.27
+0.63%
1,472.271,470.891,484.151,466.47
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.39%
2,399.95
+9.34
+0.39%
2,390.612,387.312,409.702,373.97
Q1 2026 earnings • released • EPS beat +51.25% • Revenue beat +∞%
See results
PRLD:NASDAQ
Prelude Therapeutics Inc
$4.66
+0.43%
(+0.020) 1D
$4.66
0.00% (0.00)
After hours
Closed: May 13, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRLD...
Open
$4.57
High
$4.81
Low
$4.42
Mkt. cap
371.14M
Avg. vol.
496.51K
Volume
12.00
52-wk high
$5.54
52-wk low
$0.75
EPS
-$1.29
Beta
1.11
Shares outstanding
48.27M
No. of employees
79
News stories
From sources across the web
About Prelude Therapeutics Inc
CEO-
Employees79
Founded2016
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Last report
May 12, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.13 / -$0.27
+51.25%beat
Revenue / Est. (USD)
4.58M / 0.00
+∞%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
6.50M
5.64M
4.58M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.78M
21.71M
16.79M
13.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.41M
5.21M
4.90M
5.16M
Operating expense
32.19M
26.92M
21.69M
18.76M
Total operating expenses
32.19M
26.92M
21.69M
18.76M
Operating income
-32.19M
-20.42M
-16.05M
-14.18M
Other non operating income
963.00K
693.00K
891.00K
3.79M
EBT including unusual items
-31.23M
-19.72M
-16.46M
-10.38M
EBT excluding unusual items
-31.23M
-19.72M
-15.16M
-10.38M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-31.23M
-19.72M
-16.46M
-10.38M
Net profit margin
-
-303.46%
-291.79%
-226.75%
Earnings per share
-0.41
-0.26
-0.20
-0.13
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-31.76M
-19.99M
-15.63M
-13.79M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more